Tag Archives: Y khoa Việt Nam

M2BPGi (Mac-2 Binding Protein Glycosylation Isomer) is a novel, non-invasive biomarker for assessing liver fibrosis and predicting liver cancer risk

Cirrhosis and liver cancer are among the leading causes of death in Vietnam, with some of the highest incidence rates in the Asia-Pacific region. Early diagnosis plays a crucial role in treatment and improving the quality of life for patients. In a collective effort to address this challenge, M2BPGi – a blood biomarker test – promises a breakthrough in the early diagnosis of liver cancer and cirrhosis.

The founding congress of the Vietnam Society of Interventional Gastrointestinal Endoscopy (VIGES): A significant milestone for Vietnamese medicine

On the morning of January 4, 2025, the founding congress of the Vietnam Society of Interventional Gastrointestinal Endoscopy (VIGES) was successfully held in the main hall of Bach Mai Hospital (Hanoi), opening a new chapter for the field of gastroenterology in Vietnam.